Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database
This data is the supplementary data for a manuscript entitled "Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database. In our study, we revealed the distinct adverse event (AE) profile...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Dataset |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Xu, Yuanyuan |
| description | This data is the supplementary data for a manuscript entitled "Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database. In our study, we revealed the distinct adverse event (AE) profiles of two marketed oral small-molecule drugs, namely apremilast and deucravacitinib. |
| doi_str_mv | 10.17632/p7g3bspg6x |
| format | Dataset |
| fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_17632_p7g3bspg6x</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_17632_p7g3bspg6x</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_17632_p7g3bspg6x3</originalsourceid><addsrcrecordid>eNqVT7tOw0AQvCYFAip-YHsUiLGUSHQRSkRN6K3N3cZe6c532l075IP4T5wQiZpqNKN5aJx7qBZP1WpZvzyXVVvvtbTLrxv3vQ4jiRLQSL0poGr2jEYBjmwdZMEImjDGecqR_BAJggytAvdgHYEJoaUpC_kARbMwKk89fbgyYw8o1gkb6ysglA4loc8jtxyx9wRqQzjBHnVazb-12_XmYwcBDc_ynZsdMCrdX_HWPW43n2_v87PBs1FThBPKqakWzeVk83ey_p_7B8j4ZUo</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database</title><source>DataCite</source><creator>Xu, Yuanyuan</creator><creatorcontrib>Xu, Yuanyuan</creatorcontrib><description>This data is the supplementary data for a manuscript entitled "Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database. In our study, we revealed the distinct adverse event (AE) profiles of two marketed oral small-molecule drugs, namely apremilast and deucravacitinib.</description><identifier>DOI: 10.17632/p7g3bspg6x</identifier><language>eng</language><publisher>Mendeley Data</publisher><subject>Dermatology</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.17632/p7g3bspg6x$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Xu, Yuanyuan</creatorcontrib><title>Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database</title><description>This data is the supplementary data for a manuscript entitled "Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database. In our study, we revealed the distinct adverse event (AE) profiles of two marketed oral small-molecule drugs, namely apremilast and deucravacitinib.</description><subject>Dermatology</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2024</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNqVT7tOw0AQvCYFAip-YHsUiLGUSHQRSkRN6K3N3cZe6c532l075IP4T5wQiZpqNKN5aJx7qBZP1WpZvzyXVVvvtbTLrxv3vQ4jiRLQSL0poGr2jEYBjmwdZMEImjDGecqR_BAJggytAvdgHYEJoaUpC_kARbMwKk89fbgyYw8o1gkb6ysglA4loc8jtxyx9wRqQzjBHnVazb-12_XmYwcBDc_ynZsdMCrdX_HWPW43n2_v87PBs1FThBPKqakWzeVk83ey_p_7B8j4ZUo</recordid><startdate>20240704</startdate><enddate>20240704</enddate><creator>Xu, Yuanyuan</creator><general>Mendeley Data</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20240704</creationdate><title>Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database</title><author>Xu, Yuanyuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_17632_p7g3bspg6x3</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Dermatology</topic><toplevel>online_resources</toplevel><creatorcontrib>Xu, Yuanyuan</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Xu, Yuanyuan</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database</title><date>2024-07-04</date><risdate>2024</risdate><abstract>This data is the supplementary data for a manuscript entitled "Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database. In our study, we revealed the distinct adverse event (AE) profiles of two marketed oral small-molecule drugs, namely apremilast and deucravacitinib.</abstract><pub>Mendeley Data</pub><doi>10.17632/p7g3bspg6x</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | DOI: 10.17632/p7g3bspg6x |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_datacite_primary_10_17632_p7g3bspg6x |
| source | DataCite |
| subjects | Dermatology |
| title | Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T22%3A43%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Xu,%20Yuanyuan&rft.date=2024-07-04&rft_id=info:doi/10.17632/p7g3bspg6x&rft_dat=%3Cdatacite_PQ8%3E10_17632_p7g3bspg6x%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |